Phenogenomic characterization of immunomodulatory purinergic signaling in glioblastoma.

被引：0

作者：

Coy, Shannon ^{[1
]}

Lin, Jia-Ren ^{[1
]}

Wang, Shu ^{[1
]}

Stopka, Sylwia ^{[2
]}

Rashid, Rumana ^{[3
]}

Hwang, Jaeho ^{[4
]}

Khadka, Prasidda ^{[5
]}

Euskirchen, Philipp ^{[6
]}

Bandopadhayay, Pratiti ^{[5
]}

Wen, Patrick Y. ^{[5
]}

Sorger, Peter K. ^{[1
]}

Agar, Nathalie ^{[2
]}

Ligon, Keith L. ^{[7
]}

Touat, Mehdi ^{[8
]}

Santagata, Sandro ^{[2
]}

机构：

[1] Harvard Med Sch, Boston, MA 02115 USA

[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA

[4] Johns Hopkins Univ, Baltimore, MD USA

[5] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Charite Univ Med Berlin, Berlin, Germany

[7] Harvard Med Sch, Brigham & Womens Hosp, Dana, Boston, MA 02115 USA

[8] La Pitie Salpetriere Charles Foix Univ Hosp, Paris, France

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1816

引用

页数：2

共 50 条

[31] CNS cancer: new options for glioblastoma. [J].

Errico A. .

Nature Reviews Clinical Oncology, 2014, 11 (3) :124-124

[32] A nuclear localizing peptide that targets glioblastoma. [J].

Lewis, Calvin D. ;

Singh, Abhay ;

Kapoor, Vaishali ;

Hallahan, Dennis E. .

CANCER RESEARCH, 2021, 81 (13)

[33] The role of plasma GFAP as a biomarker for glioblastoma. [J].

Husain, H. ;

Savage, W. ;

Everett, A. ;

Ye, X. ;

Blair, C. ;

Romans, K. E. ;

Bettegowda, C. ;

Burger, P. ;

Grossman, S. A. ;

Holdhoff, M. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[34] COMPARISON OF GLIOBLASTOMA STEM LIKE CELLS AND GLIOBLASTOMA TISSUE USING GENE EXPRESSION AND PURINERGIC SIGNALING ANALYSES. [J].

Holland, H. ;

Wallenborn, M. ;

Kirsten, H. ;

Xu, L. -X ;

Richter, M. ;

Ahnert, P. ;

Krupp, W. ;

Ulrich, H. ;

Meixensberger, J. .

PURINERGIC SIGNALLING, 2018, 14 :S83-S83

[35] Outcomes after hospitalization in patients with recurrent glioblastoma. [J].

Coecho Barata, Pedro Miguel ;

Kamiya-Matsuoka, Carlos ;

Lee-Kim, Soo ;

Loghin, Monica Elena ;

O'Brien, Barbara Jane ;

Tremont-Lukats, Ivo .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[36] Targeting PIK3CB in glioblastoma. [J].

Fromherz, Marc R. ;

Pridham, Kevin J. ;

Sheng, Zhi .

CANCER RESEARCH, 2022, 82 (12)

[37] Phase II trial of dovitinib in recurrent glioblastoma. [J].

Ahluwalia, Manmeet Singh ;

Papadantonakis, Nikolaos ;

Venur, Vyshak Alva ;

Schilero, Cathy ;

Peereboom, David M. ;

Stevens, Glen ;

Rosenfeld, Steven ;

Vogelbaum, Michael A. ;

Elson, Paul ;

Nixon, Andrew B. ;

McCrae, Keith .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[38] Phase 2 study of aldoxorubicin in relapsed glioblastoma. [J].

Groves, Morris D. ;

Portnow, Jana ;

Boulmay, Brian C. ;

Chawla, Sant P. ;

Dinh, Hillary ;

Chawla, Shanta ;

Wieland, Scott ;

Levitt, Daniel J. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[39] Age as a prognostic factor for treatment outcomes in glioblastoma. [J].

Braun, Kelly ;

Mohapatra, Suryanarayan ;

Choi, April ;

Ahluwalia, Manmeet ;

Jia, Xuefei .

NEUROLOGY, 2017, 88

[40] Albumin levels and Prognostic Nutritional Index in glioblastoma. [J].

Bamashmos, Anas Saeed ;

Barnett, Addison ;

Ali, Assad ;

Li, Honq ;

Angelov, Lilyana ;

Barnett, Gene H. ;

Mohammadi, Alireza Mohammad ;

Chao, Samuel T. ;

Yu, Jennifer S. ;

Murphy, Erin Sennett ;

Suh, John H. ;

Stevens, Glen ;

Peereboom, David M. ;

Ahluwalia, Manmeet Singh ;

Wei, Wei .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)

← 1 2 3 4 5 →